Novartis AG (ADR) (NVS) Beats Analyst Estimates; Is Expected To Perform Well Backed By Recent Deals

In an interview with Bloomberg, Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr. results of the world’s largest drug maker by revenue, Novartis AG (ADR) (NYSE:NVS).

“I would say first that they do not really miss estimates. I mean they were a touch below by 1% on the topline and 1% on the bottom line. So I mean it is really a very small miss,” said Rundquist.

She added that we needed to focus now on the three key divisions of the company which will be part of the continuing business of Novartis AG (ADR) (NYSE:NVS) i.e. Pharmaceutical, Alcon and Sandoz.

Novartis AG (ADR) (NYSE:NVS)

On the deal between Novartis AG (ADR) (NYSE:NVS) and Google Inc. (NASDAQ:GOOGL), Rundquist said that the deal is interesting for both the companies and the deal represents a new way to thinking in healthcare, by combining bio-technology healthcare with technology.

The technology being a non-invasive way of measuring glucose, could give real-time monitoring and treatment in case of Diabetes, said Rundquist.

On 32% of sales for the company being from so-called ‘growth products,’ Rundquist feels that it is a good figure considering many new launches since 2009 which form part of this category. She added that investors need to look at the data on Phase III of LCZ 696 in the coming months, which is a new drug for chronic heart failure and can become a $5 billion drug for the company.

In another interview, Bloomberg’s Sam Fazeli, speaking on the recent results of Novartis AG (ADR) (NYSE:NVS), said that structural changes from various deals like the one with GlaxoSmithKline plc (ADR) (NYSE:GSK) & Eli Lilly and Co (NYSE:LLY), won’t be reflecting in the company’s group financials this year, as these deals will be closing by early next year.

Fazeli added that the deal with Google Inc. (NASDAQ:GOOGL) will help in bringing more innovation into Google’s latest technology in terms of the type of lenses and that they need to convince diabetes patients also that this technology is as high-quality and sensitive as other available technologies.

“What will you see with this company is that as it products, and most pharma companies, as their products switch to more specialty care products; to more oncology type products, where the prices are healthier and the costs of selling them are lower, certainly less than if you were selling to every corner shop GP, if you like, the reality is that that automatically brings down the selling and administrative costs,” Fazeli said on lowering of administrative costs.

Disclosure: none

blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Most Expensive Clothing Stores in the United States to Get Decked Out At

The 5 Biggest Kickstarter Scams That Swindled Backers’ Donations

The 10 Most Expensive Boarding Schools In the World

50 Crazy Facts About Japan You Won’t Believe

Top 10 Least Expensive Hybrid Cars to Save the Planet With

The 10 Biggest ‘Gate’ Controversies in History

The 10 States with the Highest Nursing Shortages Leaving Their Hospitals Depleted

The 10 Best Value Investment Blogs that Every Investor Must Read

The 6 Cheapest Boarding Schools in Europe 2015

The 5 Most Expensive Cars To Insure in the World

The 10 Most Common Genetically Modified Foods

10 Self-Made Billionaires Who Came From Nothing

The 10 Most Expensive Cities to Live in North America

The 13 Most Expensive Headphones in the World to Represent

The Top 20 Wealthiest Soccer Teams in 2014

4 BuzzWorthy Cannabis Stocks And Some Smoking Derivative Plays

The 10 Healthiest Fast Food Chains in America to Dine At

The 5 Most Expensive Cat Food Brands You Can Spoil Your Kitty With

The 6 Best eCommerce Platforms for Small Businesses

The 10 Worst Mistakes an Entrepreneur Can Make

The 5 Most OP Characters in League of Legends to Carry Games and Crush Foes With

The 5 Best Foods to Eat Before Running that Will Help You Pound the Pavement

10 Glaring Plot Holes in The Walking Dead that a Zombie-Filled Bus Could Drive Through

The 5 Biggest Celebrity Stoners Who Love Their Reefer

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

Top 6 Cities For The Ultra Rich to Live in Comfort

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

How to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!